// App-Quantinova.ai

e19066 : Access to new therapies: FDA accelerated approvals and the corresponding Canadian regulatory and funding decisions.

Researchers

Presenter

  • Howard John Lim

Principal Investigators

  • Melissa Hunt

  • Julia A. Beaver

  • Paul Gustav Kluetz

  • Christopher Gravel

  • Andrew Raven

  • Dean Regier

  • Cheryl Ho

Medical Centers

  • British Columbia Cancer Vancouver, and CCTG Co-chair, Vancouver, BC, Canada

  • Health Canada, Ottawa, Ontario, Canada

  • U.S. Food and Drug Administration, Silver Spring, MD

  • BC Cancer Agency, Vancouver, BC, Canada

  • BC Cancer Agency, Vancouver, BC, Canada

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved